Literature DB >> 2652578

Early experience with anti-Tac in clinical renal transplantation.

R L Kirkman1, M E Shapiro, C B Carpenter, E L Milford, E L Ramos, N L Tilney, T A Waldmann, C E Zimmerman, T B Strom.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2652578

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Transplantation.

Authors:  T E Starzl; J J Fung
Journal:  JAMA       Date:  1990-05-16       Impact factor: 56.272

Review 3.  Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.

Authors:  Thomas A Waldmann
Journal:  J Clin Immunol       Date:  2007-01-11       Impact factor: 8.317

4.  Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.

Authors:  K Tanaka; N L Tilney; K G Stunkel; W W Hancock; T Diamantstein; J W Kupiec-Weglinski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  A humanized antibody that binds to the interleukin 2 receptor.

Authors:  C Queen; W P Schneider; H E Selick; P W Payne; N F Landolfi; J F Duncan; N M Avdalovic; M Levitt; R P Junghans; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.

Authors:  B Rose; A Gillespie; D Wunderlich; K Kelley; J Dzuiba; D Shedd; K Cahill; B Zerler
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

Review 7.  Interleukin 2 receptor antagonists for kidney transplant recipients.

Authors:  Angela C Webster; Lorenn P Ruster; Richard McGee; Sandra L Matheson; Gail Y Higgins; Narelle S Willis; Jeremy R Chapman; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

Authors:  C L Tendler; S J Greenberg; W A Blattner; A Manns; E Murphy; T Fleisher; B Hanchard; O Morgan; J D Burton; D L Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

9.  Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor.

Authors:  J Burton; C K Goldman; P Rao; M Moos; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.